
After one grueling year of jumping through many hoops to maintain access to my life-saving medication, I finally placed my first factor order through my insurance company. Six months after that, I hit the “lifetime max” on the plan and was forced to find coverage elsewhere. Before the passage of the Affordable Care Act, lifetime caps and pre-existing condition exclusions were some of the primary health-system-related roadblocks experienced by members of the bleeding disorder community. Today step-therapy, copay accumulators, and high out-of-pocket costs threaten or delay our access to prescribed therapies. The fact is people with chronic health conditions such as hemophilia and VWD face a range of challenges navigating our fragmented healthcare system. Patient navigation programs can help.
References
Blackley, K., Burriss, H., Cantril, C., Kline R., Pratt-Chapman M., Rocque G., Rohan, E., Shulman, L. (2019). Patient navigation in cancer: The business case to support clinical needs. Journal of Oncology Practice. 15,11 585-590. DOI: 10.1200/JOP.19.00230
McBrien KA., Ivers N., Barnieh L., Bailey JJ., Lorenzetti DL., Nicholas D., Tonelli M., Hemmelgarn B., Lewanczuk R., Edwards A., Braun T., Manns B. (2018). Patient navigators for people with chronic disease: A systematic review. PLoS One. 2018 Feb 20;13(2):e0191980. DOI: 10.1371/journal.pone.0191980.
Meade CD., Wells KJ., Arevalo M, Calcano ER., Rivera M, Sarmiento Y., Freeman HP., Roetzheim RG. Lay navigator model for impacting cancer health disparities. (2014). Journal of Cancer Education. 2014 Sep;29(3):449-57. doi: 10.1007/s13187-014-0640-z.
Freedman, Harold M., and Rian L. Rodriguez. “History and Principles of Patient Navigation.” Cancer. 10 July 2011. https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.26262
Freeman, Harold M. “The Origin, Evolution, and Principles of Patient Navigation.” Cancer, Epidemiology, Biomarkers, and Prevention. 21.10 (2012). https://aacrjournals.org/cebp/article/21/10/1614/69026/The-Origin-Evolution-and-Principles-of-Patient
Cover My Meds. “2022 Medication Access Guide.” PDF
IBID.
Lin, Chyongchiou J., et. al. “Factors Associated with Patient Navigators’ Time Spent on Reducing Barriers to Cancer Treatment.” Journal of the National Medical Association. 110.11 (2008). https://www.sciencedirect.com/science/article/abs/pii/S0027968415315078
Jean-Pierre, Pascal., et al. “Understanding the Processes of Patient Navigation to Reduce Disparities in Cancer Care: Perspectives of Trained Patient Navigators From the Field.” Journal of Cancer Education. April 2010. https://link.springer.com/article/10.1007/s13187-010-0122-x
McVay, Sheri., et. al. “The Effect of Different Types of Navigators on Patient Outcomes.” Journal of Oncology. April 2014. https://www.jons-online.com/jons-categories?view=article&artid=3665:the-effect-of-different-types-of-navigators-on-patient-outcomes&catid=18
Cover My Meds. “2022 Medication Access Guide.” PDF